The legend that originated from Engel-Apotheke In 1668, Friedrich Jacob Merck (1621-1678) purchased Engel-Apotheke in Darmstadt. , English: Angel Pharmacy), started the road to corporate development, and Angel Pharmacy also became the origin of the subsequent family company. In 1816, Heinrich Emanuel Merck (1794-1855) took over Angel's Pharmacy and began to develop it into a global company. He began industrial-scale production for the first time. In the pharmaceutical world, he laid the foundation for the transformation of simple handcrafts into technological production. In 1827, Heinrich Emanuel Merck started industrial large-scale production. In 1900, Merck had branches or representatives in all continents of the world. In 1904, medical products were listed for the first time; liquid crystals were started. Research on materials In 1917, its subsidiaries in the United States were confiscated, and Merck and Merck became independent. In 1945, Merck lost some of its overseas branches and began to rebuild amidst the ruins. In 1971, following Asia and Latin America, The United States re-established the subsidiary "EMD". In 1995, the German Merck KGaA was established and officially listed on the Frankfurt Stock Exchange. The issuance of 2.4 billion German marks set a historical record for the largest public issuance of stocks in Germany at the time. In 2003, Erbitux entered the field of targeted cancer treatment. In 2007, Merck acquired Swiss Serono and entered the top biotechnology field. In 2010 , Merck acquired Millipore of the United States, establishing its leading position in the global life sciences market. In 2012, Merck launched the "Fit For 2018" transformation project globally. In 2014, Merck acquired Anzhi Electronic Materials, and in the same year, launched Sigma-Aldrich's acquisition of the originator of the "Merck" brand

Due to the success of its export business in the United States, Merck established a branch in New York. In 1891, Merck & Co., the American branch of Merck, was officially established. During World War I, Merck lost many of its overseas subsidiaries, including Merck & Co. By 1917, Merck & Co. had become an independent company. Today, although the two companies have the same name, they are not related in any other way.

As the founder of the Merck brand, Merck Group has the right to use the "Merck" name and trademark worldwide (except North America). In North America, Merck uses the name "EMD", derived from the initials of Emanuel Merck Darmstadt. Merck & Co. only has the right to use the name "Merck" in North America. Outside North America, "MSD" or "MSD Sharp & Dohme" or "Merck Sharp & Dohme" must be used.

Karl-Ludwig Kley, current member of the Executive Board of Merck AG

Chairman of the Executive Board

Kai Beckmann, Chairman of the Executive Board

Chief Administration Officer

Chief Administrative Officer Stefan Oschmann

CEO Pharma

Pharmaceutical CEO Bernd Reckmann

CEO Chemicals

Marcus Kuhnert, CEO Chemicals

Chief Financial Offier

Chief Financial Officer